The μ opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the μ opioid receptor

Psychopharmacology

Volumn 140, Issue 1, 1998, Pages 20-28

  Morgan, Drake ^a,b   Picker, Mitchell J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Drug discrimination; Intrinsic efficacy; Irreversible antagonists; Opioids; Pigeons

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; BETA FUNALTREXAMINE; BUPRENORPHINE; BUTORPHANOL; FENTANYL; LEVALLORPHAN; LEVOMETHADONE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALBUPHINE; NALORPHINE; OPIATE AGONIST;

ANIMAL EXPERIMENT; ARTICLE; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; PIGEON; PRIORITY JOURNAL; TASK PERFORMANCE;

ANIMALS; BUPRENORPHINE; BUTORPHANOL; COLUMBIDAE; DISCRIMINATION LEARNING; FEMALE; FENTANYL; LEVALLORPHAN; METHADONE; MORPHINE; NALBUPHINE; NALORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, MU;

EID: 0031758812     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050734     Document Type: Article

References (54)

1. Adams JU, Paronis CA, Holtzman SG (1990) Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using β-funaltrexamine. J Pharmacol Exp Ther 255:1027-1032
2. Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond Series B 220:141-162
3. Brase DA (1986) Unequal opiate cross-tolerance to morphine in the locomotor-activation model in the mouse. Neuropharmacology 25:297-304
4. Butelman ER, Winger G, Zernig G. Woods JH (1995) Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys. J Pharmacol Exp Ther 272:845-853
5. Butelman ER, Negus SS, Lewis JW, Woods JH (1996) Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys. Psychopharmacology 123:320-324
6. Colpaert FC, Janssen PAJ (1984) Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization. J Pharmacol Exp Ther 230:193-199
7. Duttaroy A, Yoburn BC (1995) The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82:1226-1236
8. Dykstra LA (1990) Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. J Pharmacol Exp Ther 254:245-252
9. Dykstra LA, Schoenbaum GM, Yarbrough J, McNutt R, Chang KJ (1993) A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration. J Pharmacol Exp Ther 267:875-882
10. Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F (1996) Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the u opioid receptor. J Pharmacol Exp Ther 278:1121-1127
11. France CP, Woods JH (1985) Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure. J Pharmacol Exp Ther 234:81-89
12. France CP, Woods JH (1987) beta-Funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons. Psychopharmacology 91:213-216
13. France CP, Woods JH (1990) Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. J Pharmacol Exp Ther 254:626-632
14. Furchgott RF (1966) The use of b-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv Drug Res 3: 21-56
15. Gmerek DE, Woods JH (1985) Effects of β-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies. J Pharmacol Exp Ther 235:296-301
16. Holtzman SG (1997) Antagonism of morphine-like discriminative effects by beta-funaltrexamine. Pharmacol Biochem Behav 57:771-777
17. Ivarsson M, Neil A (1989) Differences in efficacies between morphine and methadone demonstrated in the guinea pig ileum: a possible explanation for previous observations on incomplete opioid cross-tolerance. Pharmacol Toxicol 65:368-371
18. Kenakin TP (1993) Pharmacologic analysis of drug-receptor interaction, 2nd edn. Raven Press, New York
19. Koek W, Woods J (1989) Partial generalization in pigeons trained to discriminate morphine from saline: applications of receptor theory. Drug Dev Res 16:169-181
20. 3H]β-funaltrexamine. Mol Pharmacol 32: 321-329
21. 3H]funaltrexamine-labeled μ-opioid receptors:species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides. Mol Pharmacol 44:749-756
22. Magnan J, Paterson SJ, Tavani A, Kosterlitz HW (1982) The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Arch Pharmacol 319:197-205
23. 3H]DAMGO binding to rat brain sections. J Pharmaeol Exp Ther 267: 506-514
24. Martin TJ, Dworkin SI, Smith JE (1995) Alkylation of mu opioid receptors by β-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats. J Pharmaeol Exp Ther 272:1135-1140
25. Mattox AJ, Picker MJ, Dykstra LA (1994) Pharmacological analysis of the rate-decreasing effects of mu and kappa opioids in pigeons. Psychopharmacology 113:457-462
26. Mjanger E, Yaksh TL (1991) Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists. J Pharmacol Exp Ther 258: 544-550
27. Morgan D, Picker MJ (1996) Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug's intrinsic efficacy at the mu receptor. Behav Pharmacol 7:261-284
28. Negus SS, Picker MJ, Dykstra LA (1990) Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure. Psychopharmacology 102:465-473
29. Negus SS, Morgan D, Cook CD, Picker MJ (1996) Effects of the delta opioid agonist BW373U86 in pigeons trained to discriminate fentunyl, bremazocine and water in a three-choice drug discrimination procedure. Psychopharmacology 126:199-205
30. Paronis CA, Holtzman SG (1992) Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J Pharmacol Exp Ther 262:1-9
31. Paronis CA, Holtzman SG (1994) Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists. Psychopharmacology 114:601-610
32. Paronis CA, Waddell AB, Holtzman SG (1993) Naltrexone in vivo protects u receptors from inactivation by β-funaltrexamine, but not κ receptors from inactivation by nor-binaltorphimine. Pharmacol Biochem Behav 46:813-817
33. Picker MJ (1997) Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists. J Pharmacol Exp Ther 283:1009-1017
34. Picker MJ, Craft RM, Negus SS, Powell KR, Mattox SR, Jones SR, Hargrove BK, Dykstra LA (1992) Intermediate efficacy mu opioids:examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats. J Pharmacol Exp Ther 263:668-681
35. Picker MJ, Yarbrough J, Hughes CE, Smith MA, Morgan D, Dykstra LA (1993) Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences. J Pharmacol Exp Ther 266:756-767
36. Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA (1996) Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by mu, kappa and delta opioid agonists. J Pharmacol Exp Ther 279:1130-1141
37. Pitts RC, West JP, Hapke DM, Morgan D, Dykstra LA, Picker MJ (1996) Opioids and rate of positively reinforced behavior: II. antagonism by beta-funaltrexamine. Exp Clin Psychopharmacol 4:389-395
38. Sanchez-Blazquez P, Garzon J (1989) Evaluation of 5 receptor mediation of supraspinal opioid analgesia by in vivo protection against the β-funaltrexamine antagonist effect. Eur J Pharinacol 159:9-23
39. Schaefer GJ, Holtzman SG (1981) Morphine-like stimulus effects in the monkey: opioids with antagonist properties. Pharmacol Biochem Behav 14:241-245
40. Shannon HE, Holtzman SG (1976) Evaluation of the discriminative stimulus effects of morphine in the rat. J Pharmacol Exp Ther 198:54-65
41. Shannon HE, Holtzman SG (1977) Further evaluation of the discriminative stimulus effects of morphine in the rat. J Pharmacol Exp Ther 201:55-66
42. Shannon HE, Holtzman SG (1979) Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology 61:239-244
43. Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H (1995) Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors. Eur J Pharmacol 284:195-198
44. Takemori AE, Portoghese PS (1985) Affinity labels for opioid receptors. Annu Rev Pharmacol Toxicol 25:193-223
45. Tallarida RJ, Murray RB (1987) Manual of pharmacological calculations with computer programs, 2nd edn. Springer. New-York
46. Walker EA, Zernig G, Woods JH (1995) Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure. J Pharmacol Exp Ther 273:1345-1352
47. Young AM (1991) Discriminative stimulus profiles of psychoactive drugs. In: Melo NK (ed) Advances in substance abuse, behavioral and biological research, vol 4. Jessica Kingsley, London, pp 139-203
48. Young AM, Kapilsopoulos G, Makhay MM (1991) Tolerance to morphine-like stimulus effects of mu opioid agonists. J Pharmacol Exp Ther 257:795-805
49. Young AM, Masaki MA, Geula C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261: 246-257
50. Zernig G, Butelman ER, Eewis JW, Walker EA and Woods JH (1994) In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. J Pharmacol Exp Ther 269:57-65
51. Zernig G, Issaevitch T, Broadbear JH, Burke TF, Lewis JW, Brine GA, Woods JH (1995) Receptor reserve and affinity of mu opioid agonists in mouse antinociceplion: correlation with receptor binding. Life Sei 57:2113-2125
52. Zernig G, Burke T, Lewis JW, Woods JH (1996) Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays. J Pharmacol Exp Ther 279:23-31
53. Zernig G, Lewis JW, Woods JH (1997) Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception. Psychopharmacology 129:233-242
54. Zimmerman DM, Leander JD, Reel JK, Hynes MD (1987) Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands. J Pharmacol Exp Ther 241:374-378